Service & Software

Global Canine Tumor Screening Market Research Report 2026

This report delivers a comprehensive overview of the global Canine Tumor Screening market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Canine Tumor Screening. The Canine Tumor Screening market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Canine Tumor Screening market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Canine Tumor Screening manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
PetDx
CYTOGEN
BioChain
Small Door
ANGLE
BioChain Institute Inc.
CANCAN DIAGNOSTICS.
Segment by Type
Cut Biopsy
Needle Biopsy
Segment by Application
Pet Hospital
Clinic
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Canine Tumor Screening companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Tumor Screening Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Cut Biopsy
1.2.3 Needle Biopsy
1.3 Market by Application
1.3.1 Global Canine Tumor Screening Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pet Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Tumor Screening Market Perspective (2021–2032)
2.2 Global Canine Tumor Screening Growth Trends by Region
2.2.1 Global Canine Tumor Screening Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Canine Tumor Screening Historic Market Size by Region (2021–2026)
2.2.3 Canine Tumor Screening Forecasted Market Size by Region (2027–2032)
2.3 Canine Tumor Screening Market Dynamics
2.3.1 Canine Tumor Screening Industry Trends
2.3.2 Canine Tumor Screening Market Drivers
2.3.3 Canine Tumor Screening Market Challenges
2.3.4 Canine Tumor Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Tumor Screening Players by Revenue
3.1.1 Global Top Canine Tumor Screening Players by Revenue (2021–2026)
3.1.2 Global Canine Tumor Screening Revenue Market Share by Players (2021–2026)
3.2 Global Top Canine Tumor Screening Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Canine Tumor Screening Revenue
3.4 Global Canine Tumor Screening Market Concentration Ratio
3.4.1 Global Canine Tumor Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Tumor Screening Revenue in 2025
3.5 Global Key Players of Canine Tumor Screening Head Offices and Areas Served
3.6 Global Key Players of Canine Tumor Screening, Products and Applications
3.7 Global Key Players of Canine Tumor Screening, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Canine Tumor Screening Breakdown Data by Type
4.1 Global Canine Tumor Screening Historic Market Size by Type (2021–2026)
4.2 Global Canine Tumor Screening Forecasted Market Size by Type (2027–2032)
5 Canine Tumor Screening Breakdown Data by Application
5.1 Global Canine Tumor Screening Historic Market Size by Application (2021–2026)
5.2 Global Canine Tumor Screening Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Canine Tumor Screening Market Size (2021–2032)
6.2 North America Canine Tumor Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Canine Tumor Screening Market Size by Country (2021–2026)
6.4 North America Canine Tumor Screening Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Tumor Screening Market Size (2021–2032)
7.2 Europe Canine Tumor Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Canine Tumor Screening Market Size by Country (2021–2026)
7.4 Europe Canine Tumor Screening Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Canine Tumor Screening Market Size (2021–2032)
8.2 Asia-Pacific Canine Tumor Screening Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Canine Tumor Screening Market Size by Region (2021–2026)
8.4 Asia-Pacific Canine Tumor Screening Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Canine Tumor Screening Market Size (2021–2032)
9.2 Latin America Canine Tumor Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Canine Tumor Screening Market Size by Country (2021–2026)
9.4 Latin America Canine Tumor Screening Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Tumor Screening Market Size (2021–2032)
10.2 Middle East & Africa Canine Tumor Screening Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Canine Tumor Screening Market Size by Country (2021–2026)
10.4 Middle East & Africa Canine Tumor Screening Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 PetDx
11.1.1 PetDx Company Details
11.1.2 PetDx Business Overview
11.1.3 PetDx Canine Tumor Screening Introduction
11.1.4 PetDx Revenue in Canine Tumor Screening Business (2021–2026)
11.1.5 PetDx Recent Development
11.2 CYTOGEN
11.2.1 CYTOGEN Company Details
11.2.2 CYTOGEN Business Overview
11.2.3 CYTOGEN Canine Tumor Screening Introduction
11.2.4 CYTOGEN Revenue in Canine Tumor Screening Business (2021–2026)
11.2.5 CYTOGEN Recent Development
11.3 BioChain
11.3.1 BioChain Company Details
11.3.2 BioChain Business Overview
11.3.3 BioChain Canine Tumor Screening Introduction
11.3.4 BioChain Revenue in Canine Tumor Screening Business (2021–2026)
11.3.5 BioChain Recent Development
11.4 Small Door
11.4.1 Small Door Company Details
11.4.2 Small Door Business Overview
11.4.3 Small Door Canine Tumor Screening Introduction
11.4.4 Small Door Revenue in Canine Tumor Screening Business (2021–2026)
11.4.5 Small Door Recent Development
11.5 ANGLE
11.5.1 ANGLE Company Details
11.5.2 ANGLE Business Overview
11.5.3 ANGLE Canine Tumor Screening Introduction
11.5.4 ANGLE Revenue in Canine Tumor Screening Business (2021–2026)
11.5.5 ANGLE Recent Development
11.6 BioChain Institute Inc.
11.6.1 BioChain Institute Inc. Company Details
11.6.2 BioChain Institute Inc. Business Overview
11.6.3 BioChain Institute Inc. Canine Tumor Screening Introduction
11.6.4 BioChain Institute Inc. Revenue in Canine Tumor Screening Business (2021–2026)
11.6.5 BioChain Institute Inc. Recent Development
11.7 CANCAN DIAGNOSTICS.
11.7.1 CANCAN DIAGNOSTICS. Company Details
11.7.2 CANCAN DIAGNOSTICS. Business Overview
11.7.3 CANCAN DIAGNOSTICS. Canine Tumor Screening Introduction
11.7.4 CANCAN DIAGNOSTICS. Revenue in Canine Tumor Screening Business (2021–2026)
11.7.5 CANCAN DIAGNOSTICS. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Canine Tumor Screening Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Cut Biopsy
Table 3. Key Players of Needle Biopsy
Table 4. Global Canine Tumor Screening Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Canine Tumor Screening Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Canine Tumor Screening Market Size by Region (US$ Million), 2021–2026
Table 7. Global Canine Tumor Screening Market Share by Region (2021–2026)
Table 8. Global Canine Tumor Screening Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Canine Tumor Screening Market Share by Region (2027–2032)
Table 10. Canine Tumor Screening Market Trends
Table 11. Canine Tumor Screening Market Drivers
Table 12. Canine Tumor Screening Market Challenges
Table 13. Canine Tumor Screening Market Restraints
Table 14. Global Canine Tumor Screening Revenue by Players (US$ Million), 2021–2026
Table 15. Global Canine Tumor Screening Market Share by Players (2021–2026)
Table 16. Global Top Canine Tumor Screening Players by Tier (Tier 1, Tier 2, and Tier 3), based on Canine Tumor Screening Revenue, 2025
Table 17. Ranking of Global Top Canine Tumor Screening Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Canine Tumor Screening Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Canine Tumor Screening, Headquarters and Area Served
Table 20. Global Key Players of Canine Tumor Screening, Products and Applications
Table 21. Global Key Players of Canine Tumor Screening, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Canine Tumor Screening Market Size by Type (US$ Million), 2021–2026
Table 24. Global Canine Tumor Screening Revenue Market Share by Type (2021–2026)
Table 25. Global Canine Tumor Screening Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Canine Tumor Screening Revenue Market Share by Type (2027–2032)
Table 27. Global Canine Tumor Screening Market Size by Application (US$ Million), 2021–2026
Table 28. Global Canine Tumor Screening Revenue Market Share by Application (2021–2026)
Table 29. Global Canine Tumor Screening Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Canine Tumor Screening Revenue Market Share by Application (2027–2032)
Table 31. North America Canine Tumor Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Canine Tumor Screening Market Size by Country (US$ Million), 2021–2026
Table 33. North America Canine Tumor Screening Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Canine Tumor Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Canine Tumor Screening Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Canine Tumor Screening Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Canine Tumor Screening Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Canine Tumor Screening Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Canine Tumor Screening Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Canine Tumor Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Canine Tumor Screening Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Canine Tumor Screening Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Canine Tumor Screening Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Canine Tumor Screening Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Canine Tumor Screening Market Size by Country (US$ Million), 2027–2032
Table 46. PetDx Company Details
Table 47. PetDx Business Overview
Table 48. PetDx Canine Tumor Screening Product
Table 49. PetDx Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 50. PetDx Recent Development
Table 51. CYTOGEN Company Details
Table 52. CYTOGEN Business Overview
Table 53. CYTOGEN Canine Tumor Screening Product
Table 54. CYTOGEN Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 55. CYTOGEN Recent Development
Table 56. BioChain Company Details
Table 57. BioChain Business Overview
Table 58. BioChain Canine Tumor Screening Product
Table 59. BioChain Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 60. BioChain Recent Development
Table 61. Small Door Company Details
Table 62. Small Door Business Overview
Table 63. Small Door Canine Tumor Screening Product
Table 64. Small Door Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 65. Small Door Recent Development
Table 66. ANGLE Company Details
Table 67. ANGLE Business Overview
Table 68. ANGLE Canine Tumor Screening Product
Table 69. ANGLE Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 70. ANGLE Recent Development
Table 71. BioChain Institute Inc. Company Details
Table 72. BioChain Institute Inc. Business Overview
Table 73. BioChain Institute Inc. Canine Tumor Screening Product
Table 74. BioChain Institute Inc. Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 75. BioChain Institute Inc. Recent Development
Table 76. CANCAN DIAGNOSTICS. Company Details
Table 77. CANCAN DIAGNOSTICS. Business Overview
Table 78. CANCAN DIAGNOSTICS. Canine Tumor Screening Product
Table 79. CANCAN DIAGNOSTICS. Revenue in Canine Tumor Screening Business (US$ Million), 2021–2026
Table 80. CANCAN DIAGNOSTICS. Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
Table 84. Authors List of This Report


List of Figures
Figure 1. Canine Tumor Screening Picture
Figure 2. Global Canine Tumor Screening Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Canine Tumor Screening Market Share by Type: 2025 vs 2032
Figure 4. Cut Biopsy Features
Figure 5. Needle Biopsy Features
Figure 6. Global Canine Tumor Screening Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Canine Tumor Screening Market Share by Application: 2025 vs 2032
Figure 8. Pet Hospital Case Studies
Figure 9. Clinic Case Studies
Figure 10. Canine Tumor Screening Report Years Considered
Figure 11. Global Canine Tumor Screening Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 12. Global Canine Tumor Screening Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Canine Tumor Screening Market Share by Region: 2025 vs 2032
Figure 14. Global Canine Tumor Screening Market Share by Players in 2025
Figure 15. Global Canine Tumor Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 16. The Top 10 and 5 Players Market Share by Canine Tumor Screening Revenue in 2025
Figure 17. North America Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 18. North America Canine Tumor Screening Market Share by Country (2021–2032)
Figure 19. United States Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. Canada Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Europe Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Canine Tumor Screening Market Share by Country (2021–2032)
Figure 23. Germany Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. France Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. U.K. Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. Italy Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Russia Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Ireland Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Asia-Pacific Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Canine Tumor Screening Market Share by Region (2021–2032)
Figure 31. China Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Japan Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. South Korea Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Southeast Asia Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. India Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Australia & New Zealand Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Latin America Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Canine Tumor Screening Market Share by Country (2021–2032)
Figure 39. Mexico Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Brazil Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Middle East & Africa Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Canine Tumor Screening Market Share by Country (2021–2032)
Figure 43. Israel Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Saudi Arabia Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. UAE Canine Tumor Screening Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. PetDx Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 47. CYTOGEN Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 48. BioChain Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 49. Small Door Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 50. ANGLE Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 51. BioChain Institute Inc. Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 52. CANCAN DIAGNOSTICS. Revenue Growth Rate in Canine Tumor Screening Business (2021–2026)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies